Back to results
US 2025/0205262 A1Published application
Sphingolipid-loaded nanobiologics for immune regulation
AssigneesIcahn School of Medicine at Mount Sinai, Stichting Radboud universitair medisch centrum
InventorsAbraham J. Teunissen, Willem J. Mulder, Raphaël Duivenvoorden, Zahi A. Fayad
Life of this patent
Estimating the term…
Abstract
Provided herein are sphingolipid-loaded nanobiologics comprising: an apolipoprotein A-1 (apoA-1) or a peptide mimetic of apoA-1; a sphingolipid; and cholesterol, and uses thereof e.g., a method of innate immune regulation including stimulating a trained immunity response in a subject, and a method of treatment of cancer, comprising administering a nanobiologic composition.
Claims56
A nanobiologic composition comprising:
- (a) a apolipoprotein A-I (apoA-I) or a peptide mimetic of apoA-I;
- (b) a sphingolipid;
- and
- (c) cholesterol;
- wherein the composition is a nanoparticle having a diameter between about 8 nm and about 150 nm.
2 more elements
Dependencies are inferred from the claim text.